Encephalitis: Which are and how to treat?;Encefalitis: ¿cuáles y cómo tratar?

Revista Chilena de Infectologia

Volumn 20, Issue SUPPL. 1, 2003, Pages

  Banfi P, Antonio ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Differential diagnosis; Encephalitis; Herpes simplex; Treatment

Indexed keywords

EID: 33846165597     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Smalling T W, Sefers S E, Li H et al. Molecular approaches to detecting herpes simplex virus and enteroviruses in the central nervous system. J Clin Microbiol 2002 July; 40 (7): 2317-22.
2. Kimberlin, D W, Lin, C Y, Jacobs, R F et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001; 108: 223-9.
3. Kimberlin D W, Lin, C Y, Jacobs R F et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001; 108: 230-8.
4. Balfour H H. Antiviral drugs. N Engl J Med 1999; 340: 1255-68.
5. Lahat E, Barr J, Barkai G et al. Long term neurological outcome of herpes encephalitis. Arch Dis. Child 1999; 80: 69-71.
6. Aurelius E. Herpes simplex encephalitis: early diagnosis and immune activation in the acute stage and during long-term follow-up. Scand J Infect Dis 1993; 89: Suppl 3-626.
7. Chaudhuri A, Kennedy P G E. Diagnosis and treatment of viral encephalitis. Postgrad Med J 2002; 78: 575-83.
8. Ieven M, Demey H, Ursi D, et al. Fatal encephalitis caused by Mycoplasma pneumoniae diagnosed by the polymerase chain reaction. Clin Infect Dis 1998; 27: 1552-3.
9. Atkins J T. HSV PCR for CNS infections: pearls and pitfalls. Pediatr Infect Dis J 1999 Sep; 18(9): 823-4.
10. 10.- Domingues R B, Tsanaclis A M, Pannuti C S, et al. Evaluation of the range of clinical presentations of herpes simplex encephalitis by using polymerase chain reaction assay of cerebrospinal fluid samples. Clin Infect Dis 1997 Jul; 25(1): 86-91.
11. 11.- Whitley R J, Lakeman F. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin Infect Dis 1995 Feb; 20(2): 414-20.
12. 12.- Whitley R J, Alford C A, Hirsch M S et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 1986; 314(3): 144-9.
13. 13.- Whitley R, Arvin A, Prober C et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991; 324(7): 444-9.
14. 14.- Whitley R J, Gnann J W. Viral encephalitis: familiar infections and emerging pathogens. Lancet 2002; 359(9305): 507-13.
15. 15.- Caserta M T, Hall C B, Schnabel K et al. Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 1994; 170(6): 1586-9.
16. 16.- Yoshikawa T, Ihira M, Suzuki K et al. Invasion by human herpesvirus 6 and human herpesvirus 7 of the central nervous system in patients with neurological signs and symptoms. Arch Dis Child 2000; 83(2):170-1.
17. 17.- Domachowske J B, Cunningham C K, Cummings D L et al. Acute manifestations and neurologic sequelae of Epstein-Barr virus encephalitis in children. Pediatr Infect Dis J 1996; 15(10): 871-5.